MJUS News and Press, ETFMG U.S. Alternative Harvest ETF From 06/21/22

Aggressive M&A has yielded massive growth in revenue, locations, and free cash in FY21. Licenses in 18 states, active retailer in 16 states, and active producer in 14 states. Fantastic regulatory arbitrage opportunity, with a company already succeeding in present market condit...

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...

Ted Waller returns to discuss staying bullish but getting more realistic about the cannabis industry. Limited growth rates, margin compression and the need to keep our emotions out of investing. Buying special situations and what stocks are more concerning. For further detai...

Julian Lin returns to discuss two of his favorite cannabis plays - a REIT and an MSO. Cannabis investing philosophy (valuations should drive capital allocations). Net leases, cap rates and how legislation may affect bullish thesis. Smart acquisitions, management compensation, ...

The Green Giants portfolio fared better than the industry benchmarks and is now besting MSOS and YOLO by about 10% year-to-date. New Jersey is the most meaningful new market in 2022 and more stores and bigger grows will add much-needed revenue in the next couple of quarters. In an...

Julian Lin returns to discuss two of his favorite cannabis plays - a REIT and an MSO. Cannabis investing philosophy (valuations should drive capital allocations). Net leases, cap rates and how legislation may affect bullish thesis. Smart acquisitions, management compensation, ...

Today, we put small-cap Agrify Corporation in the spotlight for the first time. The company is seeing impressive revenue growth supplying cultivation solutions to the hemp and cannabis industries. A full investment analysis follows in the paragraphs below. For further detail...

Capital is disappearing in the cannabis industry. Mike Regan and Colin Ferrian return to discuss what investors need to understand about valuations (it's not just like tech). Grading California's main players, consumption patterns, price erosion. EBIDA over EBITDA. For a real ...

With Ascend Wellness - and perhaps other MSOs - set to sue the US government, we think it's a good time to hear directly from cannabis executives to get their thoughts on the industry. We hear from TerrAscend's Jason Wild, Ascend Wellness' Abner Kurtin, MariMed's Bob Fireman and Weedm...

We can't control the markets. Investors need patience, more institutional capital and more catalysts, but mostly patience. Matt Hawkins returns to discuss StateHouse/Harborside, the California cannabis market and the developing US picture. Advice to retail investors and why managi...